Chirra M, Elliott A, Shaikh H, McGrath J, El-Gamal D, Karnezis AN, Abdulla FR, Ikpeazu C, Leddon J, Sukari A, Zandberg DP, Johnson JM, Sun L, Wise-Draper TM. Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer , Clin Cancer Res: 2026
Waliany S, Cooper AJ, Liu SV, Gautschi O, Rotow JK, Smith KER, Weber UM, Lee DH, Loong HHF, Patel JD, Pennell NA, Nagasaka M, Patel SA, Tan DSW, Solomon BJ, Kim TM, Pall G, Riess JW, Sun L, Früh M, Uy NF, Gadgeel S, Feng J, Do A, Falcon C, Leighl NB, Baik CS, Lai GGY, Ou SI, Cheung KSY, Patil T, Mansfield AS, Weiler D, Yeap BY, Wirth LJ, Gainor JF, Drilon A, Lin JJ. Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium , Clin Cancer Res: 2026
Barsouk A, Heidlauf A, Goel K, Rushkin L, Anran Huang A, Elghawy O, Yu C, Wang L, Yang D, Kurian M, Reed-Guy L, Sun L, Singh A, Aggarwal C, Cohen RB, Langer C, Marmarelis ME. Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) , Lung Cancer, 213: 2026,108936
Yegya-Raman N, Ko K, Han IS, Mitchell JD, Zou W, Ohri N, Jabbour SK, Mak RH, Robinson C, Levin WP, Barrett L, Xia C, Berlin E, Bravo P, Carli MD, Cohen R, Hutton S, Keltz J, Wang J, Fasan O, Nagda SN, Seo A, Smith AM, Sun L, Soike M, Kole AJ, Walls G, Feigenberg SJ, Ky B. Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study , Clin Transl Radiat Oncol, 56: 2025,101070
Gobillot TA, Weinstein G, Cao A, Lee JJ, Brody RM, Basu D, O'Malley BW Jr, Farwell DG, Cannady S, Lin A, Lukens J, Gentile M, Newman JG, Chalian AA, Sun L, Lakshmipathy D, Cohen RB, Rasskeh CH, Rajasekaran K. Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery , Laryngoscope: 2025
Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X, Brown EJ, You J, Mirabello L, Mishra SK, Shimunov D, Brody RM, Pearson AT, Gimotty PA, Diab A, Jalaly JB, Basu D. Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer , J Natl Cancer Inst, 117: 2025,1366-1376
Liu KL, Watts A, Grady CB, Liu G, Patel D, Balaratnam K, Liu SV, Montenegro GB, Nie Y, Nieva J, Herrmann A, Marrone K, Lam V, Sun F, Dowell J, Schwartzman W, Velcheti V, Fankuchen O, Ullah T, Villaruz L, Nguyen M, Weiss J, Patel S, Miller K, Iams W, Chandrasekhara K, Tompkins W, Patil T, Aisner D, Camidge DR, Hwang WT, Sun L, Marmarelis ME. Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC , JTO Clin Res Rep, 6: 2025,100876
Sun L, Marmarelis ME, Aggarwal C. Management of Patients With EGFR Exon 20-Mutant Advanced Non-Small Cell Lung Cancer , J Clin Oncol, 43(13): 2025
Cohen RB, Jimeno A, Hreno J, Sun L, Wallén-Öhman M, Millrud CR, Sanfridson A, Garcia-Ribas I. Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors , Invest New Drugs: 2025
Barsouk A, Elghawy O, Watts A, Reed-Guy L, Tompkins W, Chandrasekhara K, Grady CB, Iams W, Sun F, Liu G, Patel D, Nieva JJ, Marrone KA, Velcheti V, Liu SV, Patil T, Weiss J, Schwartzman W, Villaruz LC, Hermann A, Aisner DL, Hwang WT, Camidge DR, Sun L, Singh AP, Cohen RB, Aggarwal C, Langer CJ, Marmarelis ME. Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis , Lung Cancer, 203(108551): 2025
